Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive
Jingru Wang1, Bo Yao2, Yutian Zhang1
1Department of Health Management of the Guangdong Second Provincial General Hospital; Department of Biotechnology of the College of Life Science and Technology; State Key Laboratory of Bioactive Molecules and Drugg ability Assessment, Jinan University, Guangzhou, 510632, China.
Journal of Nanobiotechnology
|December 16, 2025
Abstract
No abstract available in PubMed .


